Over 9.1 million people globally live with Type 1 diabetes — including 1.8 million children and adolescents.1
Asia Pacific Region: Estimated People Living with T1D ~1.1 million with Annual Growth Rate ~5.9%.2 Greater China Region: Estimated People Living with T1D ~630,000 with Annual Growth Rate ~6.5%.3
Many lose up to 32 healthy years due to complications and lack of access to modern care.4
Automate care. Challenge Diabetes
Millions across Asia Pacific and Greater China are living with the daily burden of managing blood glucose. It is time to change that
Empower Lives with Automated Insulin Delivery [AID]
AID systems combine insulin pumps and continuous glucose monitors with smart algorithms to deliver insulin precisely when it's needed.
Improved glycemic control and reduced hypoglycemia5
Increased time-in-range and better sleep quality6
Restored quality of life for children, caregivers, and working adults5
Take Action
Join the Movement
-
As Global Healthcare Leaders to advocate for reimbursement and access
-
As Clinicians to educate and empower patients with AID options
-
As Industry Partners to innovate and scale solutions for diverse populations
-
As Policy Makers to make AID systems part of national diabetes strategies
Why Act Now?
Over 750,000 children in Asia Pacific and Greater China regions are living with T1D — many without access
to
modern care2,3
Early diabetes technology adoption reduces long-term complications and healthcare costs.
Take Action
Statement to Endorse
We recommend that the following model language be incorporated into current and future guidelines promulgated by professional societies and government agencies:
The standard of care for glycemic management in youth and adults with T1D is an AID system.
All People living with T1 Diabetes and other patients with insulin- dependent diabetes must be given a choice to use an AID system at the time of diagnosis or as soon after diagnosis as possible.
All People living with T1 Diabetes and other patients with insulin- dependent diabetes must be given a choice to use an AID system at the time of diagnosis or as soon after diagnosis as possible.
All People living with T1 Diabetes and other patients with insulin- dependent diabetes must be given a choice to use an AID system at the time of diagnosis or as soon after diagnosis as possible.
All People living with T1 Diabetes and other patients with insulin- dependent diabetes must be given a choice to use an AID system at the time of diagnosis or as soon after diagnosis as possible.
Automate care. Challenge Diabetes
We extend our heartfelt gratitude to everyone who is championing this movement to improve access to Automated Insulin Delivery (AID). Your support is helping restore healthy years, empower lives, and bring hope to millions living with Type 1 diabetes.
Organizational Endorsers
Authors
Banshi Saboo, Satish Garg, Richard M. Bergenstal, Tadej Battelino, Antonio Ceriello, Pratik Choudhary, Martin De Bock, Nancy Elbarbary, Gregory Forlenza, Ana Maria Gomez, Bruno Grassi Corrales, Julia Mader, David O’Neal, and Peter Schwarz for the Call-to-Action Coalition
Individual Endorsers
Halis K. Akturk, MD, Harpreet Bajaj, MD, Tadej Battelino, MD, Katrien Benhalima, MD, Richard M. Bergenstal MD, Emanuele Bosi, MD, Antonio Ceriello, MD, Manoj Chawla, MD, Alice G. Cheng, MD, Pratik Choudhary, MD, Ignacio Conget, MD, Martin De Bock, MD, Asma Deeb, MD, Osagie Ebekozien, MD, Nancy Elbarbary, MD, Gregory Forlenza, MD, Denise Franco, MD, Daphne Gardner Tan Su-Lyn, MD, Satish Garg, MD, Ana Maria Gomez, MD, Bruno Grassi Corrales, MD, Irl B. Hirsch, MD, Alicia Jenkins, MD, Tim Jones, MD, Shashank Joshi, MD, Partha Kar, MD, Francine Kaufman, MD, Jothydev Kesavadev, MD, Tomasz Klupa, MD, Lori Laffel, MD, Warren Lee, MD, David Maahs, MD, Julia Mader, MD, Chantal Mathieu, MD, Viswanathan Mohan, MD, Sun Joon Moon, MD, Medha Munshi, MD, Kirsten Norgaard, MD, David O’Neal, MD, Bruce Perkins, MD, Sarit Polsky, MD, Jane Reusch, MD, Banshi Saboo, MD, Antonio Saleme, MD, Peter Schwarz, MD, Viral Shah, MD, Jennifer Sherr, MD, Carol Wysham, MD, Fabian Yap Kok Peng, MD, and Muhammad Yazid Jalaludin, MD.